Zacks Research Analysts Lower Earnings Estimates for WTW

Willis Towers Watson Public Limited (NASDAQ:WTW - Free Report) - Analysts at Zacks Research dropped their Q1 2025 earnings per share estimates for shares of Willis Towers Watson Public in a research note issued to investors on Wednesday, April 9th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $3.22 for the quarter, down from their prior forecast of $3.31. The consensus estimate for Willis Towers Watson Public's current full-year earnings is $17.32 per share. Zacks Research also issued estimates for Willis Towers Watson Public's Q2 2025 earnings at $2.75 EPS, Q3 2025 earnings at $3.08 EPS, Q4 2025 earnings at $7.89 EPS, FY2025 earnings at $16.94 EPS, Q1 2026 earnings at $4.00 EPS, Q2 2026 earnings at $3.63 EPS, Q3 2026 earnings at $3.38 EPS, Q4 2026 earnings at $7.93 EPS, FY2026 earnings at $18.95 EPS, Q1 2027 earnings at $4.63 EPS and FY2027 earnings at $22.20 EPS.

Willis Towers Watson Public (NASDAQ:WTW - Get Free Report) last posted its quarterly earnings data on Tuesday, February 4th. The company reported $8.13 EPS for the quarter, topping analysts' consensus estimates of $8.01 by $0.12. The firm had revenue of $3.04 billion during the quarter, compared to analyst estimates of $3.05 billion. Willis Towers Watson Public had a negative net margin of 0.99% and a positive return on equity of 20.02%. The company's revenue was up 4.2% on a year-over-year basis. During the same quarter last year, the business posted $7.44 EPS.

Remove Ads

Other analysts have also issued reports about the company. UBS Group upgraded Willis Towers Watson Public from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $344.00 to $395.00 in a report on Tuesday, March 18th. Evercore ISI raised Willis Towers Watson Public from an "in-line" rating to an "outperform" rating and upped their price target for the company from $357.00 to $373.00 in a report on Wednesday, January 8th. Barclays upped their target price on shares of Willis Towers Watson Public from $302.00 to $316.00 and gave the company an "underweight" rating in a research note on Friday. Wells Fargo & Company dropped their price objective on Willis Towers Watson Public from $380.00 to $345.00 and set an "overweight" rating for the company in a research note on Tuesday, January 14th. Finally, Keefe, Bruyette & Woods reiterated an "outperform" rating and issued a $387.00 target price on shares of Willis Towers Watson Public in a research note on Wednesday, April 9th. One analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $346.38.

Willis Towers Watson Public Stock Down 0.3 %

Shares of WTW traded down $0.86 during trading hours on Friday, reaching $327.16. The company's stock had a trading volume of 553,568 shares, compared to its average volume of 561,208. The firm has a market cap of $32.62 billion, a price-to-earnings ratio of -327.16, a P/E/G ratio of 2.95 and a beta of 0.68. The company has a quick ratio of 1.72, a current ratio of 1.98 and a debt-to-equity ratio of 0.66. The company has a 50 day moving average of $327.10 and a two-hundred day moving average of $316.11. Willis Towers Watson Public has a 1-year low of $245.04 and a 1-year high of $344.14.

Willis Towers Watson Public Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Monday, March 31st will be paid a $0.92 dividend. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.12%. This is an increase from Willis Towers Watson Public's previous quarterly dividend of $0.88. Willis Towers Watson Public's dividend payout ratio is -368.00%.

Insider Buying and Selling

In other Willis Towers Watson Public news, insider Julie Jarecke Gebauer sold 3,384 shares of the company's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $335.77, for a total value of $1,136,245.68. Following the completion of the sale, the insider now owns 74,417 shares of the company's stock, valued at approximately $24,986,996.09. This represents a 4.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.22% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. USA Financial Formulas bought a new stake in Willis Towers Watson Public in the 1st quarter valued at $1,140,000. CX Institutional lifted its position in shares of Willis Towers Watson Public by 16.7% in the first quarter. CX Institutional now owns 928 shares of the company's stock valued at $314,000 after buying an additional 133 shares during the last quarter. Handelsbanken Fonder AB boosted its position in Willis Towers Watson Public by 15.6% during the first quarter. Handelsbanken Fonder AB now owns 36,129 shares of the company's stock worth $12,210,000 after purchasing an additional 4,878 shares during the period. Avanza Fonder AB bought a new stake in shares of Willis Towers Watson Public during the 1st quarter worth about $2,201,000. Finally, GAMMA Investing LLC grew its position in shares of Willis Towers Watson Public by 20.1% in the first quarter. GAMMA Investing LLC now owns 2,981 shares of the company's stock valued at $1,007,000 after purchasing an additional 499 shares during the last quarter. 93.09% of the stock is currently owned by institutional investors.

Willis Towers Watson Public Company Profile

Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. It operates through two segments: Health, Wealth & Career and Risk & Broking. The company offers strategy and design consulting, plan management service and support, broking and administration services for health, wellbeing, and other group benefit program, including medical, dental, disability, life, voluntary benefits and other coverages; actuarial support, plan design, and administrative services for pension and retirement savings plans; retirement consulting services and solutions; and integrated solutions that consists of investment discretionary management, pension administration, core actuarial, and communication and change management assistance services.